The global choroid plexus disorder treatment market is expected to experience significant growth, reaching US$ 262.3 million by 2034, driven by advancements in brain imaging technologies, targeted therapies, and minimally invasive surgical techniques. North America is currently leading the market due to its advanced healthcare infrastructure, while Asia Pacific is projected to be a fast-growing region.